Exactis Innovation and PeriPharm partner to enhance real-world evidence studies

Exactis Innovation and PeriPharm have announced a strategic collaboration aimed at establishing a comprehensive resource hub for real-world evidence (RWE) studies.

Exactis Innovation, the National Centre of Excellence in personalized medicine, operates a Pan-Canadian platform that generates real-world insights from 10,000 patients across 16 cancer care institutions in Canada. This extensive data resource supports the collection of molecular and clinical data, fueling research initiatives focused on improving cancer survivorship through data-driven decisions.

PeriPharm contributes its expertise in health economic and outcomes research and market access projects, and the company’s PROxy Network collects patient-reported outcomes (PROs), offering valuable insights into patient experiences and outcomes.

By combining Exactis’ extensive data resources with PeriPharm’s expertise in PRO collection, the collaboration aims to generate patient-centered evidence. This evidence can inform clinical decisions, address market needs, and support decision-making processes within government agencies and the pharmaceutical industry. Kostas Trakas, CEO at Exactis, emphasized the potential impact of this partnership, stating,

“Our partnership with PeriPharm underscores our commitment to empowering the healthcare ecosystem with actionable insights derived from real-world data (RWD). Together with our government and industry partners, we are poised to catalyze transformative advancements in cancer care and beyond.”

The partnership aims to improve patient care by empowering the healthcare ecosystem with actionable insights derived from RWD. The collaboration will leverage RWD and PROs to develop evidence-based solutions that align with patient needs. Jean Lachaine, Partner at PeriPharm, emphasized the significance of this collaboration, saying,

“This collaboration marks a significant milestone in our collective efforts to harness the power of RWE in driving healthcare innovation. Through this collaboration, we aim to facilitate the development of evidence-based solutions that resonate with patient needs and ultimately enhance healthcare outcomes.”